The Mycoplasma Testing Market is projected to reach $2,943.09 million by 2032

From GlobeNewswire: 2025-05-01 04:41:00

The Mycoplasma Testing Market is projected to reach USD 2,943.09 million by 2032, with a CAGR of 13.53% between 2024 and 2032. The U.S. market accounted for USD 322.13 million in 2023 and is expected to grow at a 13.37% CAGR. Biologics’ increasing use in therapeutic development is driving demand for mycoplasma testing tools.

Key companies in the market include Thermo Fisher Scientific, Lonza Group, and Merck KGaA, among others. The market scope covers North America, Europe, Asia Pacific, Middle East & Africa, and Latin America. The Kits & Reagents segment dominated in 2023, with PCR technology leading the market due to its sensitivity and specificity.

Pharmaceutical & Biotechnology Companies held a 36.12% market share in 2023, relying on mycoplasma testing for quality control in aseptic manufacturing settings. PCR-based technologies are expected to remain essential in quality assurance for pharmaceutical and biotechnology sectors. The market’s growth is driven by the increasing pipeline of biologics and biosimilars. The demand for microbial testing approaches is on the rise due to advancements in individualized medicine and biologics like monoclonal antibodies and CAR-T treatments. The mycoplasma testing market is segmented by product, technology, application, and end-use, with North America leading in market share at 40.25% in 2023.

Regional analysis shows North America leading in mycoplasma testing market share in 2023, driven by biopharma companies and strong regulatory frameworks. Meanwhile, Asia Pacific is expected to have the fastest CAGR, supported by government programs in countries like China and India to improve biologics manufacturing capabilities.

SNS Insider offers a detailed report on the mycoplasma testing market, including key points like market dynamics, statistical insights, and competitive landscape. With a focus on providing accurate market data and insights, SNS Insider aims to help clients navigate changing market conditions with confidence.



Read more at GlobeNewswire: Mycoplasma Testing Market Size to Hit USD 2943.09 Million